Impact of CAR T cell therapy product in the clinical outcome of patients with relapsed/refractory diffuse large B-cell lymphoma.

Authors: Ajinkya Buradkar, Aishwarya Khemkar, Han Yu, Megan Herr, Alex Niu, Matthew Joseph Cortese, Dorothy C. Pan, Grant Schofield, Marco L. Davila, Francisco J. Hernandez-Ilizaliturri

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e19002

Source: Full article

---

Abstract

e19002